-+ 0.00%
-+ 0.00%
-+ 0.00%

Sutro Biopharma Doses First Patients in Phase 1 Trial of STRO-004 for TF-Expressing Solid Tumors

Reuters·12/03/2025 13:00:37

Please log in to view news